Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
Biocept (BIOC) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $21.81 M
According to Biocept 's latest financial reports the company's total liabilities are $21.81 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Biocept - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $22.01 M | -4.03% |
| 2021-12-31 | $22.93 M | -3.46% |
| 2020-12-31 | $23.75 M | 263.73% |
| 2019-12-31 | $6.53 M | 14.44% |
| 2018-12-31 | $5.7 M | -6.17% |
| 2017-12-31 | $6.08 M | -12.09% |
| 2016-12-31 | $6.91 M | 0.37% |
| 2015-12-31 | $6.89 M | 1.25% |
| 2014-12-31 | $6.8 M | -50.61% |
| 2013-12-31 | $13.78 M | -52.22% |
| 2012-12-31 | $28.85 M | 65.48% |
| 2011-12-31 | $17.43 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | $70.8 M | 224.60% | 🇺🇸 USA |
 Exact Sciences EXAS | $3.32 B | 15,147.93% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.36 B | 1,565.52% | 🇺🇸 USA |